Latest News & Updates
Breaking News
1 day ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Akums Launches DCGI-Approved Triple-Action Combination Therapy for Diabetic Peripheral Neuropathic Pain
Akums secures DCGI approval for a triple-action fixed-dose combination targeting diabetic peripheral neuropathic pain, marking a regulatory milestone for domestic FDC development.
Pharma Now Editorial Team
Evommune Reports Phase 2b Failure for EVO756 in Chronic Spontaneous Urticaria at 12 Weeks
Evommune's EVO756 failed to hit its UAS7 primary endpoint at 12 weeks in Phase 2b, triggering capacity and compliance decisions for manufacturing teams.
Pharma Now Editorial Team
Idorsia Appoints Roland Wandeler as CEO, Effective October 2026
Idorsia names Roland Wandeler CEO from October 2026, signalling a commercial execution focus across its insomnia, hypertension, and rare disease portfolio.
Pharma Now Editorial Team
Kowa Submits NCX 470 NDA to FDA, Triggering €3 Million Milestone Payment to Nicox
Kowa files NCX 470 NDA with FDA, starting a 12-month review clock and triggering a €3M milestone to Nicox.
Pharma Now Editorial Team
